by The global Sperm Count Test Market is estimated to be valued at US$ 517.5 million or Mn in 2023 and is expected to exhibit a CAGR of 12.5% over the forecast period 2023-2030, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Sperm count test is a fertility test used to measure the concentration of sperm in a man’s semen and check sperm quality. It helps determine fertile ability and identify conditions such as varicocele and infections that may influence sperm production or function. The test result provides clinicians with important information to evaluate fertility potential and assist couples looking to conceive. It has applications in infertility diagnosis and treatment planning. Demand is rising owing to growing male infertility rates and delayed parenthood globally.
Market key trends:
One of the key trends in the sperm count test market is the increasing popularity of home-based and direct-to-consumer test kits. Various companies now offer self-sampling and easy to use home kits that can detect overall sperm concentration and provide quality analysis without requiring in-clinic visits. They are more affordable and offer privacy and convenience. The availability of such easy-to-use test options is boosting market growth. Secondly, advanced technologies such as computer-assisted sperm analysis are gaining traction. These automated and digitized systems analyze multiple parameters including morphology, motility, and concentration in a more accurate, fast and objective manner compared to manual methods. Their adoption is increasing in diagnostic centers and fertility clinics.
Porter’s Analysis:
Threat of new entrants: Low capital requirement for new companies to enter the market may increase competition in the industry.
Bargaining power of buyers: Large customer base allows buyers to negotiate lower prices from suppliers and manufacturers in the market.
Bargaining power of suppliers: Suppliers face intense competition as the market consists of many players, reducing their bargaining power over buyers.
Threat of new substitutes: Alternative fertility testing methods and developing technologies present potential threats to the growth of sperm count test market.
Competitive rivalry: Intense competition exists among the existing players leading to pricing pressures.
Key Takeaways
The global Sperm Count Test Market Trend is expected to witness high growth, exhibiting a CAGR of 12.5% over the forecast period, due to increasing male infertility rates. With rising age of first-time fathers and lifestyle changes, sperm count levels are decreasing.
Regionally, North America is expected to dominate the sperm count test market during the forecast period. This is attributed to increasing awareness about male fertility and egg freezing in countries like the US and Canada. Moreover, easy access to advanced healthcare facilities and growing number of fertility clinics also support the market growth in the region.
Key players operating in the Sperm Count Test market include LLC Medical Group, Abbot Laboratories, CooperSurgical Inc., Hamilton Thorne Ltd., Medical Electronic Systems, Microptic S.L., ContraVac INC, MotilityCount Aps, DNA Diagnostics Center, Prestige Consumer Healthcare, Sandstone Diagnostics, bioMerieux SA, ASKA Pharmaceuticals, Clinical Genetics Pty Ltd, Halotech DNA, SAS MARKit, Trak Fertility, UEBE Medical GmbH, Vitrolife, Welling Home Health. These players are focusing on new product launches and geographic expansions to gain higher market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
